Sell Sitagliptin (486460-32-6)

Chemical name: (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one

Molecular formula: C₁₆H₁₅F₆N₅O

Molecular Weight: 407.32

Merck's diabetes treatment drug Sitagliptin Phosphate, known as commodity JANUVIA (TM), in August 8, 2006 first allowed to market in Mexico and in October 17, 2006 in the United States to obtain FDA approval, is the first approved Listed on the Second-peptide peptidase (DPP-IV) inhibitors

Usage: Type 2 diabetes treatment drug